
The NIH’s Most Reckless Cuts Yet
Ending clinical trials with no warning can put patients at risk.

Ending clinical trials with no warning can put patients at risk.

Soda is still here—just with new cans and new slogans.

The prospect of a journey to China turned the writer’s gaze toward her own family.

The fallout from the Signal breach is only just beginning.

The likely accidental deaths of four Americans in the Baltic state will not by themselves stop plans for redeployment. And they shouldn’t.

Organizations that explicitly valued impartiality and independence have become stridently critical of Israel.

If you think of personal time only as “not work,” you could be missing out on truly enriching experiences.

Fang Fang’s newly translated novel uncovers the brutal, buried history of land reform in China.

The president’s strategy for targeting foreigners endangers the rights of Americans too.

Some of the winning and honored entries in this year’s annual photo competition

The brothers’ new reality series looks like a showcase for dude-bro supremacy. But the girlfriends steal the limelight.

One small business has paid nearly $30,000 in the past two months.

Much of the faith’s central traditions run counter to the aspirations of this new Christ-curious class.

The response to Signalgate reveals a disjuncture between the seriousness with which MAGA treats foreign enemies and perceived domestic ones.

The 25 most consequential collections from the past 25 years

A goofy Washington tradition devolves.

The new Daredevil series explores the humanity of its superhero.

The president’s officials must know that what they did in the Signal group chat was wrong—and dangerous.

Israel may be paying the price for its prime minister’s political survival.

Mariam Rahmani’s debut novel is both charmingly familiar and totally unpredictable.